1. Home
  2. ULH vs PRTC Comparison

ULH vs PRTC Comparison

Compare ULH & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Logistics Holdings Inc.

ULH

Universal Logistics Holdings Inc.

HOLD

Current Price

$23.04

Market Cap

462.1M

Sector

Industrials

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$15.44

Market Cap

464.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULH
PRTC
Founded
1932
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.1M
464.3M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
ULH
PRTC
Price
$23.04
$15.44
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
48.1K
3.3K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,461,708,000.00
N/A
Revenue This Year
$4.02
N/A
Revenue Next Year
$3.02
N/A
P/E Ratio
N/A
$8.09
Revenue Growth
N/A
N/A
52 Week Low
$12.78
$13.30
52 Week High
$30.76
$19.92

Technical Indicators

Market Signals
Indicator
ULH
PRTC
Relative Strength Index (RSI) 68.36 44.80
Support Level $14.23 $15.60
Resistance Level $25.67 $17.98
Average True Range (ATR) 1.69 0.34
MACD 0.31 0.05
Stochastic Oscillator 92.49 58.79

Price Performance

Historical Comparison
ULH
PRTC

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: